Drug resistance variants to the KRAS G12C inhibitors, sotorasib and adagrasib, in H23 lung cancer cells. Comparison of gRNA z -scores for the sotorasib treated arm versus plasmid library, and the adagrasib treated arm versus plasmid library is shown. Predicted amino acid editing consequences are labeled for drug resistance variants. Data are the average of two independent screens performed on separate days.
